Using its proprietary drug delivery technologies, SkyePharma develops new formulations of approved pharmaceutical ingredients as well as products incorporating new chemical entities to provide a clinical benefit to patients.
|
There is one approved product in the area of topical drug delivery (Solaraze) that incorporates the Group’s proven proprietary technologies. The Group’s products are marketed in a number of countries throughout the world by leading and speciality pharmaceutical companies. SkyePharma has out-licensed its topical technologies as it is focussing on oral and inhalation technologies. |
![]() |